NS

Netscientific PLCLSE Netscientific Stock Report

Last reporting period 31 Dec, 2022

Updated 25 Sep, 2024

Last price

Market cap $B

0.018

Micro

Exchange

XLON - London Stock Exchange

NSCI.L Stock Analysis

NS

Uncovered

Netscientific PLC is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-33/100

Low score

Market cap $B

0.018

Dividend yield

Shares outstanding

23.448 B

NetScientific Plc is a healthcare medical technology company, which engages in sourcing, funding, and commercializing technologies that improve the health and well-being of people with chronic diseases. Its portfolio consists of a combination of direct investments and capital under advisory. The company has developed a customized investment and realization strategy for its portfolio companies through management, incubation, advisory services and fund-raising support. The company facilitates the companies it works with, to access the type of funding, management support and resources specific to their sector, stage of development and available opportunities. The firm's subsidiaries include EMV Capital Limited, Glycotest, Inc. and ProAxsis Limited, among others.

View Section: Eyestock Rating